Filing Details
- Accession Number:
- 0001415889-23-012375
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-18 07:05:06
- Reporting Period:
- 2023-08-17
- Accepted Time:
- 2023-08-18 07:05:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818844 | Virios Therapeutics Inc. | VIRI | Pharmaceutical Preparations (2834) | 854314201 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831127 | Scott Gregory Duncan | C/O Virios Therapeutics, Inc. 44 Milton Avenue Alpharetta GA 30009 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-17 | 25,000 | $1.25 | 57,461 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.00 to $1.25, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares at each separate price within the ranges set forth in this footnote to this Form 4.
Billionaire Hedge Funds
